310881-47-1

Basic information

• Product Name: tert-butyl 4-(pyridin-3-yloxy)piperidine-1-carboxylate
• Synonyms: tert-butyl 4-(pyridin-3-yloxy)piperidine-1-carboxylate;1-Boc-4-(3-pyridinyloxy)piperidine
• CAS NO: 310881-47-1
• Molecular Formula: C₁₅H₂₂N₂O₃
• Molecular Weight: 278.34678
• Mol File: 310881-47-1.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 391.4±32.0 °C(Predicted)
• Appearance: /
• Density: 1.125±0.06 g/cm3(Predicted)
• PKA: 4.63±0.10(Predicted)
• CAS DataBase Reference: tert-butyl 4-(pyridin-3-yloxy)piperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-(pyridin-3-yloxy)piperidine-1-carboxylate(310881-47-1)
• EPA Substance Registry System: tert-butyl 4-(pyridin-3-yloxy)piperidine-1-carboxylate(310881-47-1)

Safety Data

• Hazardous Substances Data: 310881-47-1(Hazardous Substances Data)

Upstream product

• 109-00-2 3-HYDROXYPYRIDINE 
• 109384-19-2 t-butyl 4-hydroxy piperidine-1-carboxylate 
• 5382-16-1 4-HYDROXYPIPERIDINE 
• 24424-99-5 di-tert-butyl dicarbonate 
• 1972-28-7 diethylazodicarboxylate 
• 372-47-4 3-Fluoropyridine 
• 626-64-2 pyridin-4-ol 

Downstream Products

• 1018826-45-3 3-(piperidin-4-yloxy)pyridine hydrochloride 
• 442198-32-5 (2E)-3-(4-Chlorophenyl)-N-[(1S)-2-oxo-2-({2-oxo-2-[4-(3-pyridyloxy)-1-piperidinyl]ethyl}amino)-1-(2-pyridylmethyl)ethyl]-acrylamide 
• 310881-48-2 3-((4-piperidinyl)oxy)pyridine 

Relevant articles and documents

LINEAR GLYCOSIDASE INHIBITORS

Compounds of formula (I) wherein A, R, W, Q, L, n and m have the meaning according to the claims can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.

SUBSTITUTED SULFONAMIDE COMPOUNDS

Substituted sulfonamide derivatives, a process for their preparation, pharmaceutical compositions containing these compounds, and to the use of substituted sulfonamide derivatives in the treatment or inhibition of pain and/or various disorders or disease states.

Peptide compounds

The present invention relates to a compound of the formula (I)wherein R1 is benzofuranyl substituted by halogen, or styryl substituted by halogen; R2 is substituted hydroxy, substituted mercapto or substituted sulfonyl; and X is or pharmaceutically acceptable salts thereof. The compound (1) of the present invention and pharmaceutically acceptable salts thereof possess a strong inhibitory activity on the production of nitric oxide (NO), and are useful for prevention and/or treatment of NO-mediated diseases in human being and animals.